Tolerance of a Probiotic Formula | Clinical Trial

Key information

Conditions

Safety Issues

Age range

3 day–95 day

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Full term healthy infant aged 3-95 days

Exclusion criteria

Prematurity
Low birth weight
Congenital anomalies
Chronic disease
Failure to thrive
Allergy or atopic disease
Recent exposure to antibiotics

Treatment and study plan

Probiotics

Dietary Supplement

Placebo

Dietary Supplement

Primary outcomes

Body weight (g)

Time frame: 8 weeks
Body length (cm)

Time frame: 8 weeks
Head circumference (cm)

Time frame: 8 weeks

Sponsors and collaborators

Lead sponsor

Probi AB

Industry

Registry information

Official study title

Tolerance of a Probiotic Formula Containing Lactobacilli

Important dates

Study start: 2011
Primary completion: 2011
Study completion: 2011
First posted: Apr 24, 2019
Registry last updated: Apr 25, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed